MMRGlobal Investigates Possible Patent Infringement in Singapore

MMRGlobal Investigates Possible Patent Infringement in Singapore 
LOS ANGELES, CA -- (Marketwire) -- 02/19/13 --  MMRGlobal, Inc.
(OTCQB: MMRF) today announced that as a result of recent publicity,
it has been brought to the Company's attention that vendors providing
services to the Ministry of Health in Singapore appear to be
infringing on patents (including Singapore patent number 200801954)
and other Intellectual Property (collectively, the "MMR-IP") issued
to MyMedicalRecords, Inc., a wholly owned subsidiary of MMRGlobal.
The Company has been advised that personally-controlled health
records, or Personal Health Records (PHRs), are included in programs
for the Ministry of Health, the Health Promotion Board, the Health
Sciences Authority and numerous other organizations in Singapore,
which the Company believes is clearly part of MMR's inventions that
led to its MyMedicalRecords patents. The discovery came as a result
of the Company's investigations in Australia, which were reported in
recent announcements that the Australian Government, both state and
federal, through the National E-Health Transition Authority (NEHTA),
appears to be infringing on two MyMedicalRecords patents.  
NEHTA has reportedly spent an estimated one billion Australian
dollars on a Personal Health Records program which is the subject of
the potential infringement and which it appears broadly incorporates
numerous portions of the MMR-IP. The Company has spoken with an
attorney for NEHTA. MMR suggested entering into an agreement to
exchange documents to facilitate an informal resolution to this
matter for the benefit of all parties. MMR also suggested that all
relevant parties schedule a meeting at the 2013 HIMSS Conference
starting March 3rd in New Orleans in a good faith effort to get this
resolved. 
As part of the Company's continued efforts to protect its patents,
MyMedicalRecords, Inc. announced on February 12, 2013 the filing of a
complaint in the United States for patent infringement against WebMD
Health Corp. and its wholly owned subsidiary, WebMD Health Services
Group, Inc. ("WebMD"). The complaint alleges that WebMD is infringing
on MMR's Personal Health Records patent, specifically U.S. Patent No.
8,301,466, and as a result, MMR is seeking monetary dam
ages as well
as a permanent injunction. The complaint was filed in the United
States District Court for the Central District of California, case
number CV 13-00979, on February 11th, and is available on the court's
website http://www.pacer.gov/.  
MMR has an extensive healthcare IT patent portfolio, which includes
seven U.S. patents: Nos. 8,301,466; 8,352,287; 8,352,288; 8,121,855;
8,117,646; 8,117,045; and 8,321,240. The MMR Patent Portfolio
includes nearly 400 claims as well as additional applications and
continuation applications. The patents involve inventions pertaining
to Personal Health Records, Patient Portals and other Electronic
Health Record systems. In addition to Australia and Singapore, MMR
also has been granted patents internationally in other countries of
commercial interest including New Zealand, Mexico and Japan, and has
pending applications in Canada, Hong Kong, South Korea, Israel, and
European nations. 
About MMRGlobal
 MMRGlobal, Inc., through its wholly-owned operating
subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use
online Personal Health Records ("PHRs") and electronic safe deposit
box storage solutions, serving consumers, healthcare professionals,
employers, insurance companies, financial institutions, retail
pharmacies, and professional organizations and affinity groups. The
MyMedicalRecords PHR enables individuals and families to access their
medical records and other important documents, such as birth
certificates, passports, insurance policies and wills, anytime from
anywhere using the Internet. MyMedicalRecords is built on
proprietary, patented technologies to allow documents, images and
voicemail messages to be transmitted and stored in the system using a
variety of methods, including fax, phone, or file upload without
relying on any specific electronic medical record platform to
populate a user's account. The Company's professional offering,
MMRPro, is designed to give physicians' offices an easy and
cost-effective solution to digitizing paper-based medical records and
sharing them with patients through an integrated patient portal.
Through its merger with Favrille, Inc. in January 2009, the Company
acquired intellectual property biotech assets that include anti-CD20
antibodies and data and samples from its FavId(TM)/Specifid(TM)
vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's
lymphoma. To learn more about MMRGlobal, Inc. visit
www.mmrglobal.com. View demos and video tutorials of the Company's
products and services at www.mmrtheater.com. 
Forward-Looking Statements 
 All statements in this press release
that are not strictly historical in nature, including, without
limitation, intellectual property enforcement actions, infringement
claims or litigation, intellectual property licenses, and future
performance, management's expectations, beliefs, intentions,
estimates or projections, constitute "forward-looking statements."
Such forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the Company's actual
results to be materially different from historical results or from
any results expressed or implied by such forward-looking statements.
Some can be identified by the use of words (and their derivations)
such as "need," "possibility," "potential," "intend," "offer,"
"development," "if," "negotiate," "when," "begun," "believe,"
"achieve," "will," "estimate," "expect," "maintain," "plan," and
"continue," or the negative of these words. Actual outcomes and
results of operations and the timing of selected events may differ
materially from the results predicted, and any reported results
should not be considered as an indication of future performance. Such
statements are necessarily based on assumptions and estimates and are
subject to various risks and uncertainties, including those relating
to the possible invalidity of the underlying assumptions and
estimates and possible changes or developments in economic, business,
industry, market, legal and regulatory circumstances and conditions
and actions taken or omitted to be taken by third parties, including
customers, suppliers, business partners, potential licensees,
competitors and legislative, judicial and other governmental
authorities and officials. Factors that could cause or contribute to
such differences include, but are not limited to: unexpected outcomes
with respect to intellectual property enforcement actions, claims of
intellectual property infringement and general intellectual property
litigation; our ability to maintain, develop, monetize and protect
our patent portfolio for both the Company's health IT and
biotechnology intellectual property assets in the U.S. and
internationally; the timing of milestone payments in connection with
licensing our intellectual property; our ability to establish and
maintain strategic relationships; changes in our relationships with
our licensees; the risk the Company's products are not adopted or
viewed favorably by the healthcare community and consumer retail
market; business prospects, results of operations or financial
condition; risks related to the current uncertainty and instability
in financial and lending markets, including global economic
uncertainties; the timing and v
olume of sales and installations; the
length of sales cycles and the installation process; the market's
acceptance of new product and service introductions; competitive
product offerings and promotions; changes in government laws and
regulations including the 2009 HITECH Act and changes in Meaningful
Use and the 2010 Affordable Care Act; future changes in tax
legislation and initiatives in the healthcare industry; undetected
errors in our products; the possibility of interruption at our data
centers; risks related to third party vendors; risks related to
obtaining and integrating third-party licensed technology; risks
related to a security breach by third parties; risks associated with
recruitment and retention of key personnel; other litigation matters;
uncertainties associated with doing business internationally across
borders and territories; and additional risks discussed in the
Company's filings with the Securities and Exchange Commission. The
Company is providing this information as of the date of this release
and, except as required by applicable law, does not undertake any
obligation to update any forward-looking statements contained in this
release as a result of new information, future events or otherwise.  
CONTACT: 
Michael Selsman
Public Communications Co.
ms@publiccommunications.biz
(310) 922-7033 
 
 
Press spacebar to pause and continue. Press esc to stop.